GENSIGHT BIOLOGICS - Daily - Technical analysis published on 08/25/2022 (GMT)
- 270
- 0
Oops, I was wrong about that analysis. My threshold for invalidation has been broken.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : INVALID
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Strongly bullish
Technical indicators
44%
17%
39%
My opinion
Bullish above 3.380 EUR
My targets
3.917 EUR (+7.19%)
4.221 EUR (+15.52%)
My analysis
All elements being clearly bullish, it would be possible for traders to trade only long positions (at the time of purchase) on GENSIGHT BIOLOGICS as long as the price remains well above 3.380 EUR. The buyers' bullish objective is set at 3.917 EUR. A bullish break in this resistance would boost the bullish momentum. The buyers could then target the resistance located at 4.221 EUR. If there is any crossing, the next objective would be the resistance located at 4.760 EUR. However, beware of bullish excesses that could lead to a possible short-term correction; but this possible correction would not be tradeable.
Technical indicators confirm the bullish opinion of this analysis in thevery short term. However, be careful of excessive bullish movements. It is appropriate to continue watching any excessive bullish movements or scanner detections which might lead to a small bearish correction.
Force
0
10
6.6
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Londinia. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
GENSIGHT BIOLOGICS rating 3.654 EUR. The price registered an increase of +3.93% on the session and was traded between 3.526 EUR and 3.738 EUR over the period. The price is currently at +3.63% from its lowest and -2.25% from its highest.3.526
3.738
3.654
The Central Gaps scanner detects the formation of a bullish gap marking the strong presence of buyers against sellers at the opening. This formed a quotation gap.
Opening Gap UP
Type : Bullish
Timeframe : Openning
So that you have an overall view of the price change, here is a table showing the variations over several periods:
Technical
Technical analysis of GENSIGHT BIOLOGICS in Daily shows a strongly overall bullish trend. The signals given by the moving averages are 89.29% bullish. This strong bullish trend is confirmed by the strong signals currently being given by short-term moving averages. The Central Indicators scanner does not detect any result on moving averages that would impact this trend.
Technical indicators are slightly bullish. There is therefore considerable uncertainty about the continuation of the increase.
Central Indicators, the detector scanner for these technical indicators has recently detected several signals:
Pivot points : price is over resistance 2
Type : Neutral
Timeframe : Daily
MACD crosses DOWN its Moving Average
Type : Bearish
Timeframe : Daily
An analysis of the price chart with the Central Patterns scanner (detector of chart patterns and resistances and supports) shows a result that can have an impact on the price change:
Near support of triangle
Type : Bullish
Timeframe : Daily
Central Candlesticks, the scanner specialised in Japanese candlesticks, detects a bullish signal that could support the hypothesis of a small rebound in the very short term:
Upside gap
Type : Bullish
Timeframe : Daily
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 1.795 | 2.888 | 3.380 | 3.654 | 3.696 | 4.221 | 4.760 |
| Change (%) | -50.88% | -20.96% | -7.50% | - | +1.15% | +15.52% | +30.27% |
| Change | -1.859 | -0.766 | -0.274 | - | +0.042 | +0.567 | +1.106 |
| Level | Major | Major | Major | - | Intermediate | Intermediate | Intermediate |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 3.201 | 3.265 | 3.391 | 3.455 | 3.581 | 3.645 | 3.771 |
| Camarilla | 3.464 | 3.481 | 3.499 | 3.516 | 3.533 | 3.551 | 3.568 |
| Woodie | 3.231 | 3.281 | 3.421 | 3.471 | 3.611 | 3.661 | 3.801 |
| Fibonacci | 3.265 | 3.338 | 3.383 | 3.455 | 3.528 | 3.573 | 3.645 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 2.329 | 2.975 | 3.297 | 3.943 | 4.265 | 4.911 | 5.233 |
| Camarilla | 3.354 | 3.443 | 3.531 | 3.620 | 3.709 | 3.798 | 3.886 |
| Woodie | 2.168 | 2.894 | 3.136 | 3.862 | 4.104 | 4.830 | 5.072 |
| Fibonacci | 2.975 | 3.344 | 3.573 | 3.943 | 4.312 | 4.541 | 4.911 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 1.409 | 1.729 | 2.245 | 2.565 | 3.081 | 3.401 | 3.917 |
| Camarilla | 2.530 | 2.607 | 2.683 | 2.760 | 2.837 | 2.913 | 2.990 |
| Woodie | 1.506 | 1.778 | 2.342 | 2.614 | 3.178 | 3.450 | 4.014 |
| Fibonacci | 1.729 | 2.049 | 2.246 | 2.565 | 2.885 | 3.082 | 3.401 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
Technical indicators
Moving averages
| RSI (14): | 62.58 | |
| MACD (12,26,9): | 0.2860 | |
| Directional Movement: | 24.863 | |
| AROON (14): | 50.000 | |
| DEMA (21): | 3.683 | |
| Parabolic SAR (0,02-0,02-0,2): | 4.449 | |
| Elder Ray (13): | 0.174 | |
| Super Trend (3,10): | 3.385 | |
| Zig ZAG (10): | 3.636 | |
| VORTEX (21): | 1.0840 | |
| Stochastique (14,3,5): | 42.15 | |
| TEMA (21): | 3.795 | |
| Williams %R (14): | -51.80 | |
| Chande Momentum Oscillator (20): | 0.874 | |
| Repulse (5,40,3): | -0.5650 | |
| ROCnROLL: | 1 | |
| TRIX (15,9): | 1.5620 | |
| Courbe Coppock: | 62.58 |
| MA7: | 3.622 | |
| MA20: | 3.256 | |
| MA50: | 2.710 | |
| MA100: | 2.486 | |
| MAexp7: | 3.571 | |
| MAexp20: | 3.307 | |
| MAexp50: | 2.930 | |
| MAexp100: | 2.945 | |
| Price / MA7: | +0.88% | |
| Price / MA20: | +12.22% | |
| Price / MA50: | +34.83% | |
| Price / MA100: | +46.98% | |
| Price / MAexp7: | +2.32% | |
| Price / MAexp20: | +10.49% | |
| Price / MAexp50: | +24.71% | |
| Price / MAexp100: | +24.07% |
Quotes :
-
15 min delayed data
-
Euronext Paris
News
The latest news and videos published on GENSIGHT BIOLOGICS at the time of the analysis were as follows:
- GenSight Biologics Reports Interim Financial Results for the First Half of 2022
- GenSight Biologics reports 5 years’ data showing sustained efficacy and safety following one-time treatment with LUMEVOQ®
- GenSight Biologics Announces Participation and Presentation of GS010 Clinical Data at EUNOS 2022
- GenSight Biologics Announces Publication of a Study of the Impact of LHON Disease on the Lives of Patients and Relatives in Journal of Neuro-Ophthalmology
- GenSight Biologics: Annual General Meeting on May 25, 2022
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis GENSIGHT BIOLOGICS - Daily